References
- Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427–443
- Calop J, Limat S, Fernandez C. Pharmacie clinique et thérapeutique. Ed.3, Elsevier Masson 2008;(3):248–268
- Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997;40:443–448
- Abraham C, Ruslan M. Interactions between the host innate immune system and microbes in Inflammatory Bowel Disease. Gastroenterology 2011;140:1729–1737
- Bing X, Crusius J, Meuwissen S, Peña A. Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. WJG 1998;4:446–458
- Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Gut 1995;36:718–723
- Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004;113:427–437
- Rafa H, Amri M, Saoula H, et al. Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: a study in Algerian patients. J Interferon Cytokine Res 2010;30:691–697
- Hokari R, Kato S, Matsuzaki K, et al. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 2001;31:153–163
- Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577–594
- Sekirov I, Russell SL, Antunes CM, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90:859–904
- Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gutmicrobiota: friends or foes? Nat Rev Immunol 2010;10:735–744
- Renes IB, Verburg M, Van Nispen DJ, et al. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int J Colorectal Dis 2002;17:317–326
- Hans W, Schölmerich J, Gross V, Falk W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol 2000;12:267–273
- Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO). Guidelines for the evaluation of probiotics in food; 2002
- Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008;14:1585–1596
- Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108–114
- Osman N, Adawi D, Ahrne S, et al. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig Dis Sci 2004;49:320–327
- Abdelouhab K, Rafa H, Toumi R, et al. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics. Immunopharmacol Immunotoxicol 2012;34:590–597
- Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterol 1990;98:694–702
- Touil-Boukoffa C, Bauvois B, Sancéau J, et al. Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-γ levels. Biochimie 1998;80:739–744
- Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002;8:71–80
- McCarthy J, O’Mahony L, O’Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975–980
- Wu X, Vallance BA, Boyer L, et al. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 2008;294:G295–G306
- Kleerebezem M, Vaughan EE. Probiotic and Gut Lactobacilli and Bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 2009;63:269–290
- Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroentero 1994;107:1643–1652
- Kumar KG, Dhamotharan R, Kulkarni N, et al. Embelin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol 2011;11:724–773
- Southey A, Tanaka S, Murakami T, et al. Pathophysiological role of nitric oxide in rat experimental colitis. Int J Immunopharmacol 1997;19:669–676
- McCafferty DM, Miampamba M, Sihota E, et al. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999;45:864–873
- Hibbs JBJ, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1998;157:87–94
- Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF"KB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705–4708
- Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Current Drug Targets – Inflammation & Allergy 2005;4:471–479
- Petrof E, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-кB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004;127:1474–1487
- Perdigon G, Galdeano MC, Valdez JC, Medici M. Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002;56:S21–S26
- Macpherson AJ, Harri NL. Interactions between commensal intestinal bacteria and the immune system. Nature Rev Immunol 2004;4:478–485
- Renes IB, Boshuizen JA, Van Nispen DJ, et al. Alterations in Muc2 biosynthesis and secretion during dextran sulfate sodium-induced colitis. Am J Physiol Gastrointest Liver Physiol 2002;282:382–389
- Faure M, Moennoz D, Montigon F, et al. Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 2003;48:1366–1373
- Tytgat K, Van der Wal J, Einerhand A, et al. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun 1996;224:397–405
- Van Der Sluis M, De Koning BA, De Bruijn AC, et al. Muc2-deficient mice spontaneously develop colitis, indicating that Muc2 is critical for colonic protection. Gastroenterology 2006;131:117–129
- Mack DR, Ahrne S, Hyde L, et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003;52:827–833
- Caballero-Franco C, Keller K, De Simone C, Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G315–G322